Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1650 of 2529 entries
View as:

Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01297491 Org: User:
Start: 05/31/11 End: 10/31/14 Due: 10/31/15

A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT00567879 Org: User:
Start: 04/30/08 End: 05/31/11 Due: 05/31/12

Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03631199 Org: User:
Start: 12/21/18 End: 06/07/27 Due: 06/07/28

Phase III Study in Refractory Behcet's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00995709 Org: User:
Start: 10/31/09 End: 07/31/10 Due: 07/31/11

Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06161051 Org: User:
Start: 10/03/22 End: 12/07/22 Due: 12/07/23

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

Phase: N/A Priority: Normal
NCT ID: NCT00574743 Org: User:
Start: 01/31/02 End: - Due: -

Tasigna in Glivec-resistant or Intolerant Patients in CML

Phase: N/A Priority: Normal
NCT ID: NCT01206088 Org: User:
Start: 02/28/09 End: 09/30/12 Due: 09/30/13

Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01959412 Org: User:
Start: 11/30/13 End: 03/31/14 Due: 03/31/15

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00770965 Org: User:
Start: 09/10/08 End: 09/17/09 Due: 09/17/10

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05153135 Org: User:
Start: 05/08/20 End: 07/31/20 Due: 07/31/21

Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)

Phase: N/A Priority: Normal
NCT ID: NCT04143919 Org: User:
Start: 01/31/20 End: 06/11/21 Due: 06/11/22

Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03696771 Org: User:
Start: 12/27/18 End: 10/19/20 Due: 10/19/21

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01163227 Org: User:
Start: 05/31/10 End: 09/30/11 Due: 09/30/12

A Study to Assess the Long-term Safety of QVA149

Phase: N/A Priority: Normal
NCT ID: NCT01120717 Org: User:
Start: 04/30/10 End: 12/31/11 Due: 12/31/12

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT02040584 Org: User:
Start: 12/20/13 End: 02/10/16 Due: 02/10/17

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01125514 Org: User:
Start: 05/31/10 End: 08/31/11 Due: 08/31/12

Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00418769 Org: User:
Start: 06/30/06 End: - Due: -

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01956669 Org: User:
Start: 10/08/14 End: 11/05/19 Due: 11/05/20

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01830010 Org: User:
Start: 06/28/13 End: 08/21/18 Due: 08/21/19

A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02148133 Org: User:
Start: 07/23/14 End: 09/05/17 Due: 09/05/18

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Phase: N/A Priority: Normal
NCT ID: NCT01698905 Org: User:
Start: 12/20/12 End: 01/29/25 Due: 01/29/26

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00918957 Org: User:
Start: 06/30/09 End: 05/31/11 Due: 05/31/12

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

Phase: N/A Priority: Normal
NCT ID: NCT01596062 Org: User:
Start: 03/31/12 End: 03/31/13 Due: 03/31/14

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

Phase: N/A Priority: Normal
NCT ID: NCT01219699 Org: User:
Start: 10/05/10 End: 04/16/20 Due: 04/16/21

RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT00410124 Org: User:
Start: 11/30/06 End: 10/31/11 Due: 10/31/12